A multicenter and post-marketing surveillance study to evaluate the safety and effectiveness of a sodium alginate-based raft-forming antacid oral suspension in Indian patients with heartburn and indigestion

Read full text Summarise with VIRAT
Authors: S. R. Ramakrishnan, Jitendra Anand, Indraneel Basu, Partha Pratim Kalita, Jejoe Karankumar, Shivani Acharya, Mahesh Namdeo Belhekar
Cited by: 0
References: 18

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: This study evaluated the safety and effectiveness of a sodium alginate-based raft-forming antacid oral suspension in Indian patients with heartburn and indigestion. Methods: This multicenter post-marketing surveillance study, conducted across five centers in India, included adult patients with heartburn and indigestion prescribed a sodium alginate-based antacid suspension (10-20 ml after meals and at bedtime) for 7 days. Patients were evaluated on day 8 (±2). Effectiveness was assessed by adequate symptom relief, improvement in RDQ frequency and severity scores, reduction in symptom duration, and improvement in night-time symptoms. Safety was evaluated based on reported adverse drug reactions and global tolerability assessments by patients and investigators. Results: Of 319 enrolled patients, 297 completed the study. After 7 days, adequate relief was reported by 95.6% for heartburn and 96.6% for indigestion. RDQ frequency and severity scores significantly improved (both ~74-76% reduction; p

Fields of Study & Subjects

Gastroesophageal reflux and treatments Gastrointestinal motility and disorders Dental Erosion and Treatment

Publication details

Journal / source
International Journal of Research in Medical Sciences
Volume
14
Issue
4
Pages
1518–1525
Publication date
30 March 2026
Language
EN